Chatbots and Conversational Agents in Mental Health: A Review of the Psychiatric Landscape
Beth Israel Deaconess Medical Center · Harvard University
Abstract
The aim of this review was to explore the current evidence for conversational agents or chatbots in the field of psychiatry and their role in screening, diagnosis, and treatment of mental illnesses.
A systematic literature search in June 2018 was conducted in PubMed, EmBase, PsycINFO, Cochrane, Web of Science, and IEEE Xplore. Studies were included that involved a chatbot in a mental health setting focusing on populations with or at high risk of developing depression, anxiety, schizophrenia, bipolar, and substance abuse disorders.
Citation impact
- FWCI
- 55.75
- Percentile
- 100%
- References
- 22
Authors
5- AVAditya Vaidyam
Beth Israel Deaconess Medical Center, Harvard University
- HWHannah Wisniewski
Beth Israel Deaconess Medical Center, Harvard University
- JHJohn Halamka
Beth Israel Deaconess Medical Center, Harvard University
- MSMatcheri S. Kashavan
Beth Israel Deaconess Medical Center, Harvard University
- JTJohn TorousCorresponding
Beth Israel Deaconess Medical Center, Harvard University
Topics & keywords
- PsycINFO
- Psychoeducation
- Psychiatry
- Mental health
- Chatbot
- MEDLINE
- Psychology
- Anxiety
- Good health and well-being